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Recent advances in microbiome sequencing have rendered new insights into the role 
of	the	microbiome	in	human	health	with	potential	clinical	implications.	Unfortunately,	
the	 presence	 of	 host	 DNA	 in	 tissue	 isolates	 has	 hampered	 the	 analysis	 of	 host-	
associated	bacteria.	Here,	we	present	a	DNA	isolation	protocol	for	tissue,	optimized	
on	 biopsies	 from	 resected	 human	 colons	 (~2–	5	mm	 in	 size),	which	 includes	 reduc-
tion	of	human	DNA	without	distortion	of	relative	bacterial	abundance	at	the	phylum	




of Firmicutes,	Bacteroidetes,	 γ-	Proteobacteria,	 and	Actinobacteria assessed by qPCR. 
Our	optimized	protocol	was	validated	in	the	setting	of	two	large	clinical	studies	on	
521 in vivo acquired colon biopsies of 226 patients using shotgun metagenomics. The 
resulting bacterial profiles exhibited alpha and beta diversities that are similar to the 
diversities	 found	by	16S	rRNA	amplicon	sequencing.	A	direct	comparison	between	
shotgun	metagenomics	and	16S	rRNA	amplicon	sequencing	of	15	forceps	tissue	biop-
sies showed similar bacterial profiles and a similar Shannon diversity index between 
the	sequencing	methods.	Hereby,	we	present	the	first	protocol	for	enriching	bacterial	
DNA	from	tissue	biopsies	that	allows	efficient	isolation	of	all	bacteria.	Our	protocol	
facilitates analysis of a wide spectrum of bacteria of clinical tissue samples improving 
their applicability for microbiome research.
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1  |  INTRODUC TION
The rapidly growing field of microbiome research is steadily re-
vealing the role of the microbiome in human health and diseases. 
Functions of the gut microbiome are diverse and essential for 
many	biological	processes	involved	in	metabolism,	tissue	homeo-
stasis,	 and	 immunity	 (Lynch	 &	 Pedersen,	 2016).	 Changes	 in	 mi-






cent technologies have facilitated bacterial profiling on colon tis-
sues,	which	allows	more	localized	analysis	(Saffarian	et	al.,	2019)	
and may be more accurate in differentiating between healthy 








The	 study	 of	microbiome	 composition	 of	 solid	 tissue	 samples,	
however,	does	not	come	without	challenges.	Whole	tissue	isolates	
contain	 large	 bulks	 of	 host	DNA,	 overshadowing	 the	 presence	 of	
single-	cell	 organisms	 and	 viruses.	 While	 polymerase	 chain	 reac-
tion	 (PCR)	 is	 a	 valuable	 technique	 to	 identify	minority	 sequences,	
the field of microbiome research is slowly moving toward shotgun 




the	 ability	 to	 discriminate	 between	microbial	 species	 and	 analyze	
their	gene	content	including	potential	virulence	factors	(Ranjan	et	al.,	
2016).	This	may	be	crucial	to	discriminate	between	a	pathogen	and	
a	commensal	bacterium	at	 the	species	 level	 (Taddese	et	al.,	2019).	
Unfortunately,	the	application	of	shotgun	metagenomic	sequencing	




to-	human	 DNA	 ratio.	 These	methods	 include	 filtering	 out	 human	
cells	 by	 size	 (Marotz	 et	 al.,	 2018),	 antibody-	mediated	 filtration	 of	




results	 in	most	 efficient	 bacterial	DNA	 enrichment	 (Marotz	 et	 al.,	
2018;	Nelson	et	al.,	2019).	Bacterial	DNA	enrichment	contributes	to	
the identification of minority species and higher sequencing cover-
age	of	the	microbial	genomes	present	in	human	tissue	samples,	thus	
improving the taxonomic and functional analysis of the microbiome 
in these samples.
One	 of	 the	 caveats	 of	 bacterial	 DNA	 enrichment	 is	 that	 the	
method	of	DNA	isolation	affects	the	microbiome	profile	(Biesbroek	
et	 al.,	 2012;	Bjerre	 et	 al.,	 2019;	Horz	 et	 al.,	 2010;	Knudsen	 et	 al.,	
2016;	Marotz	et	al.,	2018;	Nelson	et	al.,	2019;	Thoendel	et	al.,	2016).	
Bacteria	 differ	 in	 their	 susceptibility	 to	 lysis,	 resulting	 in	 the	 ten-











reflects the bacterial composition of the sample.
The immense advance in our understanding of the human gut 
microbiome has been largely based on stool samples; not tissue. 









ment,	 mutanolysin	 treatment,	 heat	 shock,	 and	 bead-	beating.	 Our	
protocol	efficiently	lyses	Gram-	positive	bacteria,	while	maintaining	
the	DNA	derived	from	the	Gram-	negative	bacteria.	Our	optimized	
protocol enriches the bacterial content of biopsies ranging from 
~2– 5 mm and was validated in the context of two large prospective 
studies on in vivo acquired tissue biopsies using shotgun metage-
nomics. This method will contribute to reproducible research in the 




2.1  |  Collection of human colon biopsies
Ex vivo residual resected colon material was obtained at the depart-
ment	 of	 pathology	 of	 the	 Radboudumc	 in	Nijmegen	 between	 2017	
and	2018,	in	accordance	with	Dutch	legislation.	Twenty	forceps	biop-
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study of residual colon resections because anonymous use of redun-
dant tissue for research purposes is part of the standard treatment 
agreement	with	patients	 in	the	Radboudumc,	to	which	patients	may	
opt-	out.	Resected	colons	were	transported	from	the	operation	room	






biopsies of about 2 mm that were used as a proxy for biopsies taken 
during	 colonoscopy.	 After	 collection,	 biopsies	 were	 snap-	frozen	 in	
cryo-	tubes	in	liquid	nitrogen	and	stored	at	−80°C.
In vivo collected forceps biopsies for shotgun metagenomic se-
quencing were obtained from patients that came for a screening 




tients without known colon diseases. Two healthy appearing tissue 
biopsies	were	 taken	with	 sterile	 forceps	 in	 colon	ascendens	 (VR1)	





Arnhem	 Nijmegen	 (CMO	 2016–	2616	 and	 CMO	 2016–	2818)	 and	
the board of the Radboudumc. Patients who had taken antibiotics 
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2.2  |  Bacterial DNA isolation protocol
The	bacterial	DNA	isolation	strategy	involved	bacterial	DNA	enrich-
ment	through	human	cell	lysis	and	DNAse	treatment	(Figure	1,	upper	
part),	 which	 was	 followed	 up	 by	 our	 previously	 optimized	 bead-	
beating	protocol	(Figure	1,	lower	part)	(Couto	Furtado	Albuquerque	
et	 al.,	 2017).	 Whereas	 the	 bead-	beating	 protocol	 remained	 un-
changed	 throughout	 this	 paper,	 two	 alternative	 strategies	 were	
tested	 for	 bacterial	 DNA	 enrichment.	 For	 the	 first	 strategy,	 the	
Molzym	 DNA	 isolation	 (Ultra-	Deep	 Microbiome	 prep,	 Molzym,	
2020)	kit	was	used.	The	manufacturer's	protocol	was	followed	until	
and	 including	 the	molDNAse	 inactivation	 step.	 Subsequently,	 the	
bead-	beating	 protocol	 was	 applied	 to	 assist	 in	 mechanical	 bacte-
rial	cell	lysis,	because	this	was	shown	to	result	in	a	higher	bacterial	
signal	 in	qPCR	(Figure	A1	in	Appendix	2).	For	the	second	strategy,	
we established our alternative protocol including proteinase K 
(19133,	 Qiagen)	 for	 protein	 digestion,	 Phosphate-	buffered	 saline	
(PBS)	(Braun,	220/12257974/1110)	containing	saponin	(47036-	50G,	
Sigma-	Aldrich)	 or	 Triton	 (9002-	93-	1,	 Sigma-	Aldrich)	 for	 selective	
lysis	of	host	cells,	and	TurboDNAse	(AM2239,	Qiagen)	for	host	DNA	
removal.	We	evaluated	the	effect	of	detergents,	Triton	or	saponin,	at	
different concentrations for lyses of human cells and experimented 
what	was	the	best	moment	to	include	the	biopsy	wash	(point	A	or	B)	
in	the	DNA	isolation	process	(Figure	1).
The	 lysis	of	bacterial	 cells	 included	 treatment	with	0.5	KU/mL	












2.3  |  Bacterial culturing
Collinsella intestinalis	 (DSM13280),	 Bacteroides vulgatus	 (3775	
SL(B)10),	Escherichia coli	(NTB5),	and	Streptococcus gallolyticus subsp. 
gallolyticus	 (UCN34)	 were	 cultured	 on	 Brain	 Heart	 Infusion	 agar	
plates	 supplemented	with	yeast	extract	L-	cysteine	Vitamin	K,	 and	
Hemin	 (BHI-	S;	 ATCC	medium	1293).	C. intestinalis and B. vulgatus 
were grown on plates for 48 hr under anaerobic conditions before 
transfer	to	liquid	medium	for	48–	72	hr	at	37°C.	E. coli and S. gallo-
lyticus were grown overnight on plated under aerobic conditions 
before	transfer	to	liquid	culturing	in	BHI	for	24	hr	at	37°C/5%	CO2. 






were	mixed	in	400	µ	l	(40%	B. vulgatus,	30%	E. coli,	20%,	S. gallolyti-
cus,	and	10%	C. intestinalis)	and	were	pelleted	for	each	experimental	
condition.
2.4  |  Bacterial DNA release by treatment with 
Triton and saponin









2.5  |  Effects of saponin 0.0125% on human 
tissue lysis






Samples	were	 incubated	at	37°C	 for	30	min	 to	 lyse	 the	 cells,	 and	
the supernatant was cleared from cell debris by two centrifugation 
cycles	of	10	min	at	10,000×g	at	4°C.	DNA	in	the	supernatant	was	
precipitated	with	100%	ethanol	and	centrifuged	at	10,000×g	at	4°C	
for	 20	min.	 Precipitated	DNA	was	washed	with	 70%	 ethanol	 and	
centrifuged	at	10,000×g	at	4°C	for	20	min.	Lastly,	DNA	was	air-	dried	
and resuspended dH2O.
2.6  |  Quantitative Real- Time PCRs for 16S rRNA
Each	reaction	for	qPCR	consisted	of	0.4	µM	forward	primer,	0.4	µM	
reverse	primer,	1X	Power	SYBR	Green	(A4368702,	Applied	biosys-
tems).	 The	 amount	 of	DNA	 in	 each	 reaction	was	 1	 ng	 and	0.1	 ng	
for	biopsies	that	were	~5	mm	and	~2	mm,	respectively.	Primers	for	
the	host	 (human	or	zebrafish)	and	bacteria	 (all	bacteria,	Firmicutes,	
Bacteroidetes,	 γ-	Proteobacteria,	 and	 Actinobacteria)	 were	 used	














fecal reference isolate was used as a calibrator sample for relative 
abundance.	Reference	DNA	isolated	from	human	blood	served	as	a	
negative control to set background qPCR signals.
2.7  |  Statistical analysis of qPCRs
To	 evaluate	 differences	 in	 bacterial	 content	 between	 samples,	
the	 universal	 16S	 rRNA	 signal	 of	 the	 sample	was	 calibrated	 using	
the	 universal	 16S	 rRNA	 signal	 of	 the	 positive	 control	 (ΔCt);	 a	
mock community isolate. Fold difference was calculated by 2−ΔCt. 
Metagenomic analysis revealed that the most common phyla were 
Firmicutes	 (39.8%),	 Bacteroidetes	 (16.7%),	 Actinobacteria	 (9.3%),	
Proteobacteria	 (16.4%),	Verrocumicrobia	 (0.2%)	and	others	 (17.5%)	
(Figure	4c).	Subsequently,	the	ΔCt was compared to the ΔCt in a con-
trol sample (ΔΔCt).	Fold	difference	was	calculated	by	2−ΔΔCt. Paired 
samples	were	analyzed	with	a	paired	t-	test.	In	the	case	of	unmatched	
samples,	 the	 Mann–	Whitney	 U	 test	 was	 used	 for	 comparison.	 A	
Friedman test was used to evaluate which detergent resulted in the 
most	similar	bacterial	composition	to	PBS.	All	statistical	tests	were	
performed	using	Graphpad	Prism	version	5.0.
2.8  |  Shotgun metagenomic sequencing of human 
in vivo acquired colon biopsies
DNA	 was	 isolated	 using	 our	 optimized	 protocol	 including	 the	
DNeasy	Powerlyzer	Powersoil	kit	(Qiagen),	as	described	in	Appendix	
3.	DNA	concentration	was	measured	as	described	previously.	A	total	






sample.	 Samples	 were	 measured	 for	 DNA	 concentration	 (Qubit),	
and construct length and a quality check were performed on the 
library preparation. Thirteen samples were not sequenced due to 
failed library preparation resulting in 508 successfully sequenced 
metagenomes of 224 patients (Supplementary Data S1: https://doi.
org/10.5281/zenodo.4678214).
In	 addition,	 for	 the	 comparison	 of	 16S	 rRNA	 versus	 metag-
enomics	 sequencing,	 the	 second	 set	 of	 15	 biopsy	 samples	 of	 12	
patients were selected from the BBC study that had the high-
est	 DNA	 yields.	 These	 samples	 had	 an	 average	 concentration	
of	5.9	ng/µl.	5	µl	was	used	 for	16S	 rRNA	amplification,	while	 the	
rest for metagenomics library preparation. The samples were sent 
to	 Novogene	 Bioinformatics	 Technology	 Co.,	 Ltd	 in	 Hong	 Kong	
for sequencing. Metagenomics sequencing was performed as de-
scribed	 above.	 The	V3-	V4	 region	 of	 the	 16S	 rRNA	 gene	was	 am-





was	 performed	 on	 Illumina	 NovaSeq	 6000	 platform	 to	 generate	
250	bp	paired-	end	 raw	 reads	 (Q30 > 94.8%)	 (Supplementary	Data	
S2:	https://doi.org/10.5281/zenodo.4678214).
2.9  |  Bioinformatics analysis
Quality	 control,	 trimming,	 and	 removal	 of	 adaptors	 were	 per-
formed	using	FastQC	version	0.11.9	and	trimmomatic	version	0.35.	
An	 assembly	 dataset	 was	 generated	 by	 filtering	 out	 the	 human	
reads	using	BBMap	version	38.84	with	the	GRCh38	version	of	the	
human	genome.	Filtered	reads	were	assembled	with	metaSPAdes	
version 3.13.1. The taxonomic classification of contigs was deter-
mined	with	CAT	v.	4.6	(von	Meijenfeldt	et	al.,	2019)	using	the	NCBI	
NR	as	a	database	 for	 taxonomic	assignments.	bwa	version	0.7.17	
and samtools version 1.9 were used to map all the reads to the clas-
sified contigs and the human genome and to estimate the coverage 




sample. This cutoff was used to guarantee the generation of re-
liable	profiles	 from	bacterial	 reads	 (Cattonaro	et	al.,	2018;	Louca	
et	al.,	2018;	Zeller	et	al.,	2014).	Since	this	cutoff	was	determined	
artificially,	 we	 repeated	 the	 same	 analysis	 with	 the	 full	 dataset	
(Figure	 A6a+b	 in	 Appendix	 2).	 Samples	 were	 rarified	 by	 resam-
pling the reads according to the samples with the fewest number 
of	reads.	Shannon	diversity	(alpha)	and	the	UniFrac	diversity	(beta)
(Lozupone	 &	 Knight,	 2005)	 were	 estimated	 from	 the	 taxonomic	
distribution of reads at the genus level. Diversity indices and phy-
lum level classifications were compared to values obtained from 
literature selected based on sequencing of colon tissue biopsies 
reporting Shannon diversity and phylum abundance. We did not 
perform	a	meta-	analysis	and	also	did	not	download	the	raw	data,	
but used the reported metrics as a comparison for our metagenome 
results.	 Studies	 fulfilling	 these	 criteria	were	16S	 rRNA	amplicon-	
based	(Djuric	et	al.,	2019;	Kiely	et	al.,	2018;	Momozawa	et	al.,	2011;	
Watt	et	al.,	2016).	 In	addition,	we	performed	a	direct	comparison	
between	 16S	 rRNA	 sequencing	 and	 shotgun	 metagenomics	 for	
15 samples. The shotgun metagenomic samples were processed 
as	 described	 above.	 The	 paired-	end	 reads	 generated	 from	 16S	
rRNA	sequencing	were	assigned	to	samples	based	on	their	unique	
barcodes and truncated by cutting off the barcode and primer 
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sequences.	 Paired-	end	 reads	were	merged	 using	 FLASH	 (V1.2.7;	
Magoc	&	Salzberg,	2011).	Quality	filtering	on	the	raw	tags	was	per-
formed	 under	 specific	 filtering	 conditions	 to	 obtain	 high-	quality	
clean	 tags	 (Bokulich	et	 al.,	 2013)	 according	 to	 the	Qiime	 (V1.7.0)	
quality-	controlled	process	 (Caporaso	et	 al.,	2010).	The	 tags	were	
compared	 with	 the	 reference	 database	 using	 the	 UCHIME	 algo-
rithm	to	detect	chimera	sequences	(Edgar	et	al.,	2011),	which	were	
subsequently removed to obtain effective tags. Sequence analy-
ses	were	performed	by	Uparse	software	(Edgar,	2013)	using	all	the	
effective	 tags.	 Sequences	with	 ≥97%	 similarity	were	 assigned	 to	





number corresponding to the sample with the least sequences. 
Subsequent	 analysis	 of	 Shannon	 index	 2.9	 and	 UniFrac	 distance	
0.56	was	all	performed	on	these	normalized	data	and	compared	to	
those obtained from shotgun metagenomics (Supplementary Data 
S2:	https://doi.org/10.5281/zenodo.4678214).
3  |  RESULTS
3.1  |  Whole tissue digestion including PBS wash is 
required to capture the collective tissue microbiome




washed	 tissue	 (biopsy	wash),	we	 tested	whether	 the	 biopsy	wash	
only	would	be	sufficient	 for	bacterial	analysis.	To	test	 this,	 the	bi-
opsy	and	biopsy	wash	were	isolated	separately	with	the	Ultra-	Deep	
Microbiome	prep	kit	(Molzym,	2020)	in	combination	with	our	bead-	
beating protocol. While biopsies were isolated with the full protocol 









of strategy 1 on a mock community by comparing the full protocol 
(similarly	to	the	biopsy)	to	a	part	of	the	protocol	(similarly	to	the	bi-
opsy	wash,	Path	A	 in	Figure	1).	We	 found	 that	 the	 full	 strategy	1	
protocol,	which	 includes	selective	cell	 lysis	and	DNAse	treatment,	




to continue strategy 1 as it suggests that it disfavors isolation of 
Gram-	negative	bacteria	versus	Gram-	positive	bacteria.
3.2  |  Saponin 0.0125% seems safe to use to lyse 
host cells, but not bacterial cells
Strategy	2	was	established	using	similar,	but	tweakable	steps,	includ-
ing	 protein	 digestion	with	 proteinase	K,	 selective	 human	 cell	 lysis	
with	 detergents,	 and	 DNAse	 treatment	 to	 remove	 host	 cell	 DNA	
after	 lysis.	First,	we	tested	which	detergent	would	effectively	 lyse	
human	 cells	without	 affecting	 the	 ratio	 of	 bacterial	 phyla.	Hence,	
we tested whether treatment with different concentrations of Triton 
and	saponin	would	result	 in	bacterial	DNA	release	(eDNA)	of	pure	
cultures and affected bacterial phyla in tissue biopsies compared 
to	 PBS.	 First,	 pure	 bacterial	 cultures	 of	 Streptococcus gallolyticus 
(Firmicutes),	 Bacteroides vulgatus (Bacteroidetes),	 Escherichia coli (γ-	
Proteobacteria),	and	Collinsella intestinalis (Actinobacteria)	(Figure	2a)	
were exposed to Triton and saponin. While C. intestinalis was resist-
ant	to	lysis	under	all	conditions,	B. vulgatus and S. gallolyticus were 
susceptible	 to	 lysis	 in	 the	presence	of	Triton,	with	higher	 concen-
trations	leading	to	more	eDNA.	Triton	did	not	affect	the	amount	of	
eDNA	of	E. coli and C. intestinalis. Saponin was shown to be a mild 
detergent,	as	it	only	increased	the	eDNA	of	E. coli at a concentration 
of	 0.1%.	 These	 experiments	 suggest	 that	 saponin	 concentrations	
equal	to	or	lower	than	0.025%	and	Triton	concentrations	equal	to	or	
lower	than	0.006%	are	safe	for	bacterial	lysis.
Secondly,	 it	 was	 tested	 whether	 Triton	 and	 saponin	 would	
change the bacterial composition of 20 matched tissue biopsies 
at	 phyla	 level	 from	2	patients	 (patient	1	 and	patient	2).	DNA	was	
isolated	 using	 the	 protocol	 including	 either	 saponin	 (0.0125%	 or	
0.025%)	or	Triton	 (0.025%	or	0.006%)	and	 the	 relative	abundance	
of Firmicutes,	Bacteroidetes,	Actinobacteria,	and	γ-	Proteobacteria was 
compared	 to	 isolations	 performed	 without	 detergents	 (PBS).	 For	
each	phylum,	the	detergent	creating	the	lowest	distance	to	PBS	was	
ranked	1,	 followed	by	 rank	2,	3,	 and	4	 (Figure	A4	 in	Appendix	2).	
Saponin	0.0125%	led	to	the	smallest	difference	in	abundance	with	
PBS	across	all	bacterial	phyla	(Figure	2b).	Triton	0.006%	and	Triton	
0.025%	ranked	significantly	higher	(p < 0.05 and p < 0.001 respec-
tively)	(Figure	2b).	Additionally,	the	Firmicutes to Bacteroidetes ratio 
was	only	maintained	 in	 the	saponin	0.0125%	condition	 (Figure	A5	
in	Appendix	2).	Thus,	saponin	0.0125%	preserved	relative	bacterial	
composition at phyla level within the samples and seems safe to use 
to lyse host cells.
Thirdly,	 we	 tested	 whether	 saponin	 0.0125%	 would	 mediate	




pared to tissues in PBS only (p	=	0.05)	(Figure	2c).	This	shows	that	
exposure	of	tissue	to	saponin	0.0125%	induces	lysis	of	host	cells.
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3.3  |  Strategy 2 increases the bacterial- to- 
human signal
After	 DNA	 release	 of	 human	 tissue,	 DNAse	 treatment	 should	 be	
performed	 to	 degrade	 the	 released	 DNA.	 Degradation	 of	 eDNA	
significantly	reduced	free	DNA	in	the	supernatant	(Figure	3b).	The	
significantly	lower	DNA	yield	after	DNAse	treatment	was	associated	









to	 0.53	 (CI:0.42–	0.65)	 but	 increased	 the	 bacterial	 signal	 6.8-	fold	
(CI:	 2.2–	10.52)	 (Figure	 3c).	 Triton	 0.006%	 and	 saponin	 0.0125%	
gave	an	enrichment	of	greater	 than	4	 in	both	patients	 (Figure	3c).	
Interestingly,	 also	 in	 absence	 of	 detergent	 (PBS	 control),	 DNAse	
F I G U R E  2 (a)	Saponin	0.0125%	induces	human	cell	lysis,	without	inducing	bacterial	cell	lysis.	The	effect	of	Triton	and	saponin	on	bacterial	
cell lysis was measured. This experiment was performed for Streptococcus gallolyticus(Firmicutes),	Bacteroides vulgatus (Bacteroidetes),	
Escherichia coli (γ-	Proteobacteria),	and	Collinsella intestinales (Actinobacteria).	The	ratio	between	the	concentration	in	treated	versus	untreated	
(PBS)	was	plotted.	An	increase	of	more	than	2	was	considered	relevant.	Results	show	that	Triton	affects	bacterial	cell	lysis	in	Streptococcus 
gallolyticus and Bacteroides vulgatus,	but	not	in	Escherichia coli and Collinsella intestinalis.	Saponin	only	induced	cell	lysis	at	0.1%	in	E. coli. 
(b)	Biopsies	were	isolated	with	strategy	2	in	combination	with	Triton	(Trit)	and	saponin	(Sap)	at	different	concentrations.	The	relative	
bacterial signal for Firmicutes,	Bacteroidetes,	Actinobacteria,	and	γ-	Proteobacteria	was	calibrated	with	the	universal	16S	rRNA	signal	(ΔCt)	
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treatment resulted in bacterial signal enrichment. This could be ex-
plained	by	the	presence	of	human	eDNA	due	to	human	cell	lysis	that	
may	occur	during	repetitive	heating	and	centrifugation.	Ultimately,	









3.4  |  The bacterial composition of human colon 
tissue biopsies by shotgun metagenomics resembles 
that previously reported by 16S rRNA analysis
Finally,	 we	 applied	 our	 optimized	 method	 to	 in vivo acquired co-
lonic biopsies in the context of two prospective clinical studies 
(Supplementary	Data	S1:	https://doi.org/10.5281/zenodo.4678214).	
The	range	of	bacterial	reads	was	0.24%–	40.51%	vs	16.1–	99.48%	of	
human	 reads.	Analysis	 showed	 that	 the	number	of	bacterial	 reads	
was significantly associated with bacterial abundance determined 
by	microscopy	(KruskalResult,	statistic	=	38.310,	p	value	=	4.8e−09)	












phyla were Firmicutes	 (39.8%),	Bacteroidetes	 (16.7%),	Actinobacteria 
(9.3%),	 Proteobacteria	 (16.4%),	 Verrocumicrobia	 (0.2%),	 and	 others	
(17.5%)	(Figure	4c).	Thus	far,	shotgun	metagenomics	of	microbiomes	




bution	 of	 bacterial	 phyla.	 Furthermore,	 the	 Shannon	 diversity	 of	
our	study	 (2.9)	was	within	 range	of	other	studies	 (2.4–	3.7).	Lastly,	
our	study	resulted	in	an	average	pairwise	UniFrac	distance	of	0.56	
(Figure	 4d)	which	was	 similar	 to	 the	UniFrac	 distance	 reported	 in	
Momozawa	et	al.	(0.55).
Moreover,	 15	 additional	 biopsies	 acquired	 in	 the	 follow-	up	
from BBC study participants were sequenced with both 16S 
rRNA	 sequencing	 and	 shotgun	 metagenomics.	 These	 15	 biop-
sies	have	been	selected	because	they	had	the	highest	DNA	yield	
of	 a	 larger	 pool	 of	 follow-	up	 biopsy	 tissue	 isolates,	 thereby	 al-
lowing sufficient yield for two sequencing methods of the same 
sample	 (Supplementary	 Data	 S2:	 https://doi.org/10.5281/ze-
nodo.4678214).	At	 phylum,	 class,	 order,	 family,	 and	 genus	 level,	
amplicon sequencing and shotgun highly correlated (Pearson: 
r	=	0.87,	p	=	1.80e−84)	 (Figure	4e	and	Figure	A7	 in	Appendix	2	
for	 class	 to	 species	 level).	 Only	 at	 the	 species	 level,	 there	 was	
a	 low	 correlation.	 The	 Shannon	 diversity	 and	 UniFrac	 distance	
were not significantly different between the sequencing tech-
niques (Figure 4f+g and Supplementary Data S2: https://doi.
org/10.5281/zenodo.4678214).	 Notably,	 4	 of	 the	 15	 samples	
displayed	 spirochetosis,	which	 could	 contribute	 to	 low	Shannon	
diversity indices.
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Although	bacterial	reads	are	sometimes	still	 low,	our	optimized	
bacterial	 DNA	 isolation	 protocol	 (strategy	 2)	 in	 combination	 with	
shotgun metagenomic sequencing was able to reproduce previously 
reported bacterial tissue profiles and direct comparison between 
shotgun	metagenomics	 and	 16S	 rRNA	 sequencing	 in	 samples	 se-
quenced with both methods shows high similarity. To our knowl-
edge,	 this	 is	 the	 first	 time	 that	colon	 tissue	bacterial	profiles	have	
been reported with shotgun metagenomics.
4  |  DISCUSSION
Bacterial	DNA	isolation	from	tissues	is	complicated	by	large	amounts	
of	 host	DNA.	While	 several	 strategies,	 protocols,	 and	 commercial	
kits	have	been	developed	to	tackle	this	problem,	so	far	none	of	these	






isolate	 in	 which	 the	 four	 most	 common	 phyla	 were	 represented,	
without inducing lysis of cultured bacterial cells or notably skewing 
bacterial	composition	in	clinical	biopsy	samples.	Of	note,	our	strat-
egy was shown to work also on fish gills and hence can be applied or 
tailored to other tissues similarly.
We	 started	 out	 testing	 the	 Ultra-	Deep	 Microbiome	 prep	 kit	
(Molzym,	2020)	 in	combination	with	bead-	beating	 (strategy	1)	be-
cause	 both	 methods	 perform	 well	 in	 microbiome	 research	 (Allali	
et	 al.,	 2015;	 Biesbroek	 et	 al.,	 2012;	 Knudsen	 et	 al.,	 2016;	Marotz	
et	al.,	2018;	Nelson	et	al.,	2019;	Yuan	et	al.,	2012).	The	inclusion	of	
bead-	beating	enhanced	 isolation	of	 all	 bacterial	 phyla,	 particularly	
Actinobacteria	 (Figure	A1	 in	Appendix	2).	Furthermore,	we	noticed	






of the protocol that we developed for processing fecal samples 
(Albuquerque	 et	 al.,	 2017).	 This	 protocol	 has	 been	modified	 from	
the	HMP	protocol	and	includes	an	enzymatic	lysis	step	with	muta-
nolysin,	 heat	 shock,	 and	 bead-	beating.	 Our	 bead-	beating	 process	
has	 been	 optimized	 on	 fecal	 samples	 (Albuquerque	 et	 al.,	 2017).	
Importantly,	 fine-	tuning	 of	 bead-	beating	 speed	 and	 duration	 may	
be	 required	 for	 each	 specific	 bead-	beater.	 It	 has	been	questioned	
whether	 bead-	beating	 improves	 bacterial	 DNA	 isolation	 from	 tis-
sues	 (Carbonero	 et	 al.,	 2011),	 because	 it	may	 contribute	 to	 some	
level	 of	 DNA	 degradation	 (Carbonero	 et	 al.,	 2011;	 Moen	 et	 al.,	
2016).	 However,	 according	 to	 more	 recent	 studies,	 bead-	beating	
does	not	cause	DNA	shearing	(Lim	et	al.,	2018;	Wagner	Mackenzie	
et	al.,	2015)	and	results	in	the	identification	of	extra	species	in	tissue	






that	 bead-	beating	 should	 be	 included;	 however,	 it	 has	 to	 be	 per-








study Djuric et al. Kiely et al. Watt et al.
Momozawa 
et al.
Symbol Fig. 4 Blue star Red triangle Red cross Red hexagon Red square
Firmicutes 39.8 61 52.5 46.5 – 
Bacteroidetes 16.7 27.3 39 43.2 – 
Actinobacteria 9.3 2.2 – 0.5 – 
Proteobacteria 16.4 4.5 2.5 5.1 – 
Verrucomicrobia 0.2 3.8 – – – 
Fusobacteria 0.0 0.1 1.5 – – – 
Others 17.5 1.1 4.5 4.7 – 
Shannon index 2.9 3.5 2.4 3.7 – 
I. Simpson index 5.0 20.3 – 20 – 






TA B L E  1 Microbiome	profiles	of	
human	colon	biopsies	of	our	study	(WGS)	
resemble those that have been previously 
published	(16S	rRNA)


























coplasma. The study of these types of bacteria requires a different 
approach,	 of	 which	 antibody-	mediated	 filtering	 of	 bacterial	 DNA	
may still be an option. Small adaptations in the protocol may also 
improve	 the	 detection	 of	 certain	 bacterial	 subtypes,	 albeit	 at	 the	
cost	of	 less	efficient	 isolation	of	others.	For	example,	Streptococci	




of this protocol is set on the isolation of the bacterial component of 
the	microbiome,	and	we	did	not	test	how	well	it	performs	on	yeasts.	
Hence,	adaptations	to	have	an	accurate	representation	of	yeast	may	
be	 required.	 Importantly,	 our	 shotgun	 metagenomics	 sequencing	
detected archaea and viruses in all samples (Supplementary Data S1: 
https://doi.org/10.5281/zenodo.4678214).
Our shotgun metagenome sequencing results of 508 biopsies of 
224 patients showed that we were able to produce bacterial pro-
files	with	Shannon	diversity	and	UniFrac	distance	that	is	compara-
ble	 to	16S	 rRNA	 sequencing	data	 of	 colon	 tissues,	 indicating	 that	
this sequencing method can be used for tissue microbiome profiling. 
Nevertheless,	small	differences	were	observed	between	the	bacte-
rial	composition	of	our	study	(shotgun)	and	three	other	studies	(16S	
rRNA);	we	 observed	 fewer	Bacteroidetes and more Actinobacteria. 
Importantly,	similar	differences	were	found	 in	another	study	com-
paring	 shotgun	 metagenomics	 with	 16S	 rRNA	 in	 stool	 samples.	
Ranjan	 et	 al.	 reported	 fewer	 Bacteroidetes with shotgun metage-
nomics	 (14–	21%)	 than	with	16S	rRNA	sequencing	 (34%)	and	more	
Actinobacteria	 with	 shotgun	 metagenomics	 (4–	7%)	 than	 with	 16S	
rRNA	sequencing	(0.4%)	(Ranjan	et	al.,	2016).	Hence,	the	differences	
observed between the colon tissue microbiomes of our and other 
studies may be caused by amplification biases.
While we have merged strategies from successful protocols 
and	have	created	hand-	tailored	steps	 in	 the	protocol,	 further	 test-
ing is necessary to confirm the preservation of microbial profiles 
in	 shotgun	 metagenomics	 vs	 amplicon	 sequencing	 in	 side-	by-	side	
comparisons. Our comparison of 15 samples with both shotgun 
metagenomics	and	16S	rRNA	sequencing	shows	a	high	correlation	of	
bacterial	abundance	between	both	methods	on	all	taxonomic	levels,	
except	 the	 species	 level,	 and	 a	 comparable	 Shannon	diversity	 and	
UniFrac	distance.	More	extensive	analysis	on	genus	and	species	level	
is required to firmly conclude that profiles are not skewed by the en-
richment	steps.	Additionally,	some	experiments	are	of	small	size	due	
to limited available material and the mock community only consisted 
of	4	different	bacterial	species.	However,	our	protocol	provides	more	
insight than some currently commercially available kits and allows 
for the application of tissue shotgun metagenomics with comparable 
results	to	16S	rRNA	sequencing	based	on	available	studies.
Taken	together,	here	we	show	for	the	first	time	a	protocol	to	be	
used for tissue shotgun metagenomics of colon biopsies that omits 
16S	rRNA	amplification	steps.	Our	protocol	is	mild	enough	to	main-
tain	isolation	of	Gram-	negative	bacteria,	while	it	also	includes	steps	









applies to many different research settings where it facilitates the 
analysis of a wide spectrum of bacteria. This way our protocol may 
contribute	to	fundamental	and	clinical	microbiome	research,	further	
illuminating the role of the microbiome in health and disease.
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TA B L E  A 1 Schematic	overview	of	experiments	and	material	within	this	study.	A	short	explanation	for	each	action	is	provided	below









2 big biopsies of patient nr.4 of resected 
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4 mock communities Figure	A3	in	Appendix	2
Change to independent protocol with tweakable steps; change from DNA isolation strategy 1 to 2.
Protocol setup
Detergent selection
4. Testing bacterial lysis under 
protocol conditions
Pure bacterial cultures Figure 2a
5. Testing which detergent causes 
the least difference to PBS
Total	of	20	forceps	(small)	biopsies	of	




6. Test whether the selected 









12 big biopsies of patient nr. 5 + 6 of 
resected colons
Figure 3a+b








Sequencing results with our 
method
9.	Evaluate	whether	the	number	
of bacterial reads represents 
bacterial abundance by imaging
508 clinical in vivo acquired human 
biopsies of 224 patients
Figure 4a+b




11. Compare 16S with shotgun 









The	goal	of	 this	paper	was	 to	set	up	a	protocol	 for	bacterial	DNA	
isolation from human tissues which does not distort the bacterial 
profile,	with	attention	to	the	following:




•	 Includes	 required	 steps	 for	 acquiring	 DNA	 from	 sturdy	 Gram-	
positive bacteria.
• Creates reproducible bacterial profiles by sequencing without 
16S	rRNA	amplification	bias.
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Process description (Action # in table)
	 1.	 The	 Molzym	 DNA	 isolation	 kit	 was	 selected	 because	 this	
was	 a	 well-	reported	 strategy	 for	 bacterial	 DNA	 enrichment	
from	human	tissues.	Our	personalized	bead-	beating	 (BB)	pro-
tocol	 was	 inspired	 by	 HMP	 and	 previously	 optimized	 in	 our	
laboratories	 for	 feces.	 We	 tested	 Molzym	 with	 BB	 mainly	
to	 boost	 the	 isolation	 of	 sturdy	 Gram-	positive	 bacteria	 like	
Actinobacteria.









 4. We decided to design our own lysis buffer. We tested which 
concentrations of saponin or Triton are safe to use on pure bac-
terial cultures.
 5. We tested which concentrations of saponin or Triton would a 
cause shift in the relative abundance of most common phyla in 
resected biopsies.
	 6.	 We	test	whether	saponin	0.0125%	causes	cell	lysis	by	exposing	
human resection material to protocol conditions.
	 7.	 We	 tested	 whether	 the	 biopsy	 wash	 should	 be	 included	 in	
DNAse	treatment	(washing	could	break	human	cells	and	release	
human	DNA	in	the	supernatant).
TA B L E  A 2 Primers	for	qPCR.
Target Forward primer Reverse primer References



































TA B L E  A 3 Bacterial	enrichment	using	saponin	0.0125%	and	TurboDNAse	improves	bacterial-	to-	fish	DNA	ratio	in	qPCR.	DNA	isolations	
were	performed	with	and	without	DNAse	treatment.	Ct	values	are	given	in	the	upper	part.	In	the	lower	part,	the	fold	difference	(FD)	
between	the	signal	with	and	without	DNA	isolation	is	shown.
With enrichment (Ct) Without enrichment (Ct)
Bacterial signal Host signal Bacterial signal Host signal














Average 32.114 30.294 33.115 23.215
ΔCt = Ct with – Ct without
FD Bacterial (2−ΔCt) FD Host (2−ΔCt)
FD 2.001386775 0.0073962
1/FD 0.499653546 135.20456
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 8. We tested which detergent condition resulted in the best bacte-
rial	DNA	enrichment.
 9. We validated our protocol by performing shotgun metagenomic 
sequencing on in vivo acquired human biopsies of 2 prospec-
tive clinical studies. We tested whether the number of bacterial 
reads correlated with the bacterial abundance score that was 
rendered by imaging.
 10. We evaluated whether common bacterial phyla of colon tissue 
microbiomes	 (reported	previously	 in	 literature	with	16S	 rRNA	
sequencing)	were	also	represented	in	our	samples	that	were	iso-
lated with our method (and processed with shotgun metagen-
omic	sequencing).
	11.	 We	 performed	 16S	 rRNA	 and	 shotgun	 sequencing	 on	 15	 ad-
ditional	 clinical	 biopsies	 (biopsies	with	 high	DNA	 yields	 to	 do	
both	sequencing	methods)	and	compared	bacterial	abundances,	
Shannon	diversity,	and	UniFrac	distance.
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each value is plotted relative to the mock community (ΔCt).	Paired	
t-	tests	revealed	that	DNA	from	the	biopsy	isolates	contained	a	
similar	bacterial	fraction,	albeit	with	fewer	Bacteroidetes and more 
Actinobacteria.	Hence,	whole	tissue	digestion	is	required	to	analyze	
the complete bacterial component of the tissue
F I G U R E  A 3 Ultra-	Deep	Microbiome	prep	on	bacterial	mock	






and was compared to one untreated sample (ΔΔCt).	Each	sample	
was run as a PCR duplicate of which both data points were plotted. 
Mann–	Whitney	t-	test	revealed	a	significant	decrease	compared	to	
PBS for γ-	Proteobacteria and Bacteroidetes
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F I G U R E  A 4 Effect	of	detergent	on	bacterial	composition.	Colonic	biopsies	(~3	mm)	from	2	patients	were	isolated	with	our	protocol	using	
different detergents and concentrations. The bacterial signal for Firmicutes,	Bacteroidetes,	Actinobacteria,	and	γ-	Proteobacteria was calibrated 
with	the	universal	16S	rRNA	signal	of	the	same	patient	(ΔCt)	and	was	compared	to	PBS	sample	of	the	same	patient	(ΔΔCt).	The	difference	to	
PBS was plotted
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F I G U R E  A 6 Unfiltered	data	of	
metagenomic bacterial profiles of clinical 
colon biopsies (without 20 000 bacterial 
reads	as	cutoff	value).	(a)	Overall	bacterial	
phyla profiles of all sequenced biopsies. 
(b)	Shannon	index	and	UniFrac	distance	of	
all sequenced biopsies
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APPENDIX 3
PROTOCOL
Bacterial DNA isolation from tissue with bacterial enrichment and 
bead- beating
Reference: Optimized DNA isolation method for microbiome anal-
ysis of human tissues. Carlijn Bruggeling1,	Daniel R. Garza2,	Soumia 




opsy is vortexed in PBS to release bacteria from the biopsy. This su-
pernatant	(“biopsy	wash”)	is	added	back	to	the	sample,	after	the	rest	
of the biopsy is made into a cell suspension using proteinase K. The 
sample	is	treated	with	a	soap	to	lyse	human	cells,	which	is	combined	
F I G U R E  A 7 Correlation	between	16S	rRNA	and	shotgun	sequencing	of	15	clinical	colon	biopsies.	15	follow-	up	biopsies	of	BBC	study	
patients	were	sequenced	with	both	16S	and	shotgun	sequencing	and	compared	at	class,	order,	family,	genus,	and	species	level	(a–	e,	
respectively)
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with	TurboDNAse	treatment	to	digest	external	DNA.	Subsequently,	
intact	bacteria	in	the	sample	are	sensitized	to	lysis	using	Mutanolysin	














b. Solution C1 to C6.
c.	 Beads	(0.1	mm	glass	beads).
d.	 3	sets	of	2	mL	collection	tubes.








PART 1:  BAC TERIAL ENRICHMENT






Make PBS/Proteinase K mix
4.	 Transfer	 the	 supernatant	 (“biopsy	wash”)	 to	 a	 new	 tube	 and	
keep it on ice.
5.	If	the	biopsy	is	~2	mm:	add	197	µl	of	PBS	and	3	µl	of	Proteinase	
K to the biopsy.
For	larger	biopsies:	add	180	µl	of	PBS	and	20	µl	of	Proteinase	K	
to biopsy
6. Short spin down.
7.	Incubate	samples	at	70°C,	400	rpm	15	min.
Set	incubator	to	37°C











13. Resuspend by vortexing 15 s.








21. Discard supernatant by pipetting.
22.	Store	pellets	at	−20°C	or	go	to	step	23.
PART 2:  BE AD -  BE ATING PROTOCOL
Bead- beating preparation:
23.	Add	180	µl	of	Bead	solution	+20	µl	of	mutanolysin	per	sample.
24. Resuspend by vortexing.
25.	Incubate	at	37°C	for	60	min	400	rpm.
Set	up	the	heater	at	6°C







29. Vortex tubes for 30 to 40 s.
30.	Add	mixture	to	bead	tubes.




• 6400 rpm for 30 s
• On ice for 30 s
• 6400 rpm for 30 s
Keep samples on ice
Bacterial DNA extraction
33.	Centrifuge	at	10,000×g for 2 min.
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39.	Centrifuge	at	10,000×g for 1 min.







44.	 Load	 approximately	 675	 µl	 onto	 a	 spin	 filter,	 centrifuge	 at	
10,000×g	for	1	min,	Discard	the	flow	(do	this	3	until	the	sample	is	
finished).
45.	Add	500	µl	of	solution	C5,	centrifuge	at	10,000×g for 30 s.
46.	Discard	the	flow-	through.
47.	Centrifuge	at	10,000×g for 1 min.
48. Carefully place a spin filter in a new set of collection tubes.
49.	Add	50	µl	of	solution	C6	to	the	center	of	the	membrane.
50.	Centrifuge	at	10,000×g for 30 s.
51. Discard the Spin Filter.
52.	Store	the	extracted	DNA	at	−80°C.
APPENDIX 4























• Centrifuge samples at max. speed for 15 min.
•	 Transfer	 aqueous	 phase	 into	 clean	 tubes,	 discard	 waste	 into	 a	
container in the fumehood.
•	 Add	0.6	 volumes	 of	 isopropanol	 to	 samples	 and	 incubate	 over-
night	at	−20°C.




• Pour off ethanol carefully.
•	 Leave	tubes	open	for	5	min	to	evaporate	the	remaining	ethanol.
•	 Resuspend	pellet	in	200	µl	autoclaved	milliQ.
RNase treatment of DNA extractions
•	 Add	1	µl	(10	mg/ml)	RNase	A	to	samples,	incubate	at	37°C	for	30	
min.
•	 Add	 200	 µl	 phenol:chloroform:isoamyl	 alcohol,	 mix	 thoroughly	
for 20 s.
• Centrifuge 15 min at maximum speed.
•	 Transfer	 aqueous	 phase	 into	 a	 new	 tube,	 discard	 phenol	waste	









•	 Remove	 residual	 ethanol	 by	 pipetting,	 without	 disturbing	 the	
pellet.











Forward (10 μM) 0.6	µl
Reverse (10 μM) 0.6	µl
H2O …	µl	(upto	20	µl)
DNA 5 ng
